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United States General Accounting Office
Washington, DC  20548
June 17, 2002
The Honorable James A. Traficant, Jr.
House of Representatives
Subject: Origin of the AIDS Virus
Dear Mr. Traficant:
In response to your request to review an individual’s allegations that the National
Cancer Institute’s Special Virus Cancer Program (SVCP) created the AIDS virus, we
obtained information on (1) the overall stated purposes and outcomes of SVCP, (2)
scientific assessments of the origins of the AIDS virus (HIV-1) and any possible
evidence regarding the origins of the AIDS virus at SVCP, and (3) the outcome of
recent litigation regarding the origins of the AIDS virus. On June 13, 2002, we briefed
your staff on the results of our analysis. The enclosed slides formed the basis of the
briefing we presented.
To address our objectives, we consulted experts on HIV/AIDS and on SVCP, reviewed
SVCP progress reports and summaries as well as documents that allege SVCP created
the AIDS virus. In addition, we obtained information on recent litigation involving the
individual’s allegations. In summary, we did not find evidence to support the
allegation that SVCP created the AIDS virus. Comments from the National Cancer
Institute on a draft of the briefing slides concluded that they are historically and
scientifically accurate.
We are sending copies of this report to the Secretary of Health and Human Services
and the Acting Director of the National Cancer Institute. We will also make copies
available to others on request. In addition, the report will be available at no charge on
the GAO Web site at http://www.gao.gov. Please contact me at (202) 512-7119 if you
have any questions. The major contributor to this report was Lawrence S. Solomon.
Sincerely yours,
Janet Heinrich
Director, Health CarePublic Health Issues
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Background
• An individual has alleged that the visna
virus, which caused illness and death in
Icelandic sheep, was used by the National
Cancer Institutes (NCI) Special Virus
Cancer Program (SVCP) to develop HIV-1,
the virus that has caused the global AIDS
pandemic.
• This individual cited a SVCP research
program flowchart as evidence that HIV-1
was developed intentionally in its
laboratories.
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Objectives
• Identify overall stated purposes and outcomes of
SVCP.
• Describe scientific assessments of the origins of the
AIDS virus and any possible evidence regarding the
origin of the AIDS virus at SVCP.
• Describe outcome of recent litigation involving the
individuals allegations of federal government
involvement in the origins of the AIDS virus.
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Methodology
To address our objectives, we:
• Consulted experts on HIV/AIDS and on SVCP.
They have expertise in genetics, cell biology, viral
oncology, biochemistry, internal medicine,
epidemiology, public health, and dentistry.
Some of these experts are cited by the individual
as supporters of the allegation that SVCP created
the AIDS virus.
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Methodology (continued)
• Reviewed SVCP progress reports and summaries
issued between 1967 and 1984.
• Reviewed documents that allege SVCP created the
AIDS virus.
• Obtained information on recent litigation addressing
the individuals allegations.
• Performed our work from January through May 2002
in accordance with generally accepted government
auditing standards.
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Purpose of SVCP
• NCI directed SVCP within the intramural laboratories
from 1964 to 1980. After 1980, the work of SVCP
was incorporated into NCIs broader National Cancer
Plan.
• Purpose was to find viruses in human cancer cells,
relate them to specific cancers (leukemia, etc.), and
develop means to block their effects and reduce
cancer growth.
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Purpose of SVCP
(continued)
• In 1972, SVCP developed a flowchart depicting
research program to investigate viral oncology
(the study of how viruses cause cancer).
• Outcome of SVCP did not lead to discovery of viruses
in human cancer cells, but did result in several
advances in molecular biology.
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Scientific Assessment on the
Origins of the AIDS Virus
• The first scientific evidence of HIV-1 predates the
1964 commencement of SVCP.
• HIV-1 was found in blood samples of an African man
who died in 1959. (Zhu, Tuofu et al. An African HIV-1
Sequence from 1959 and Implications for the Origin of the
Epidemic, Nature 391, no. 6667 (1998): 594-97.)
• HIV-1 was likely transferred to humans before 1955
from a subspecies of chimpanzees infected with
simian immunodeficiency virus (SIV). (Korber, Bette et
al. Timing the Ancestor of the HIV-1 Pandemic Strains, Science
288, no. 5472 (2000): 1789-96.)
Enclosure                                                                        Enclosure
 GAO-02-809R  Origin of the AIDS Virus10
Scientific Assessment on the
Origins of the AIDS Virus
(continued)
• Historical analyses of virus development have
demonstrated that while the visna virus and HIV-1
shared some common origins thousands of years ago,
mutations of key genes over time have resulted in a
wide divergence of these two viruses.
• These analyses have also demonstrated that the
laboratory combination of the visna virus and HIV-1
was highly improbable.
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Scientific Assessment on the
Origins of the AIDS Virus
(continued)
• Therefore, there is no evidence that SVCP created the
AIDS virus.
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Recent Litigation Involving
Allegations Concerning the
Origins of the AIDS Virus
• U.S. District Court (Northern District of Ohio) issued
order September 16, 1999, dismissing allegations that
the federal government developed agent that
subsequently became known as AIDS.
• U.S. Court of Appeals (Sixth Circuit) affirmed the
U.S. District Court order November 7, 2000. The
Court of Appeals referred to the allegations as having
no basis in law or in fact.
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Recent Litigation Involving
Allegations Concerning the
Origins of the AIDS Virus
(continued)
• U.S. Supreme Court denied petition to review the case
June 4, 2001.
[Graves v. Cohen, No. 98-02209 (N.D. Ohio
Sept. 16, 1999), affd 238 F. 3d 421, 2000 U.S.
App. LEXIS 29203 (6th Cir. Nov. 7, 2000), cert.
denied sub nom. Graves v. Rumsfeld, 532
U.S. 1072 (2001).]
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Comments from NCI
• We received oral comments from NCI on a draft of
this briefing. The comments stated that the
information contained in this briefing is historically
and scientifically accurate.
(290160)
